$24M Deal To End Caris Merger Suit

Law360, Wilmington (June 23, 2016, 6:36 PM ET) -- CDx Holdings Inc. on Tuesday said it has agreed to pay $24 million to option holders of CDx’s predecessor company, Caris Life Sciences, to end a long-running merger class action that wound its way to the Delaware Supreme Court last week but still could have been revived over an alleged clerical error. In the proposed settlement, CDx, the company formed from the merger of Caris and Miraca, will pay $24 million to a class of option holders whose options were repurchased by Caris in 2011.